MarketInOut Stock Screener Log In | Sign Up

Collplant Biotechnologies Ltd

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Collplant Biotechnologies Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization11.23 mln
Float1.48 mln
Earnings Date11/26/2026

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-5.34
Highly reliable

Relative Strength

95 / 100
Top performer

Debt / Equity

0.54
Moderate leverage

Pre-Tax Margin

-3,376%
Severely loss-making

ROE

-145
Deeply negative

Business Description

CollPlant Biotechnologies is an Israeli company that grows human collagen from plants and uses it to develop medical products. Its offerings include tissue fillers, wound care treatments, tendon repair solutions, and 3D-printed breast implants, with operations spanning the US, Canada, Europe, and beyond. The company also supplies collagen-based materials to other researchers and manufacturers working in regenerative medicine, and works alongside partners such as AbbVie and Stratasys to advance its technology.

Key Fundamentals

EPS-9.33
ROE-145
RPS0.24
ROIC-248
ROA-95.59
Interest Cover-82.70
EBITDA, mln-12.03
EV / EBITDA-0.40
EV / EBIT-0.37
Revenue, mln0.39
EV / Revenue12.37

Quote Details

Last 4.14
Change -0.26 (-5.91%)
Open 4.20
Volume 44,213
Turnover 183,042
Average Volume 50,022

Financial Ratios

Pre-Tax Profit Margin-3,376
Leverage Ratio2.44
Current Ratio2.27
Price / Book1.12
Price / Tangible Book1.13
Debt / Equity0.54
Price / Sales12.11

Financial Strength

Altman Z-Score-22.69
Piotroski F-Score 1 / 9
Beneish M-Score-5.34
Short Ratio0.04
Short % of Float2.81

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 12.81% 96 / 100   
1 Month 15.97% 95 / 100   
2 Months 29.78% 95 / 100   
6 Months 0.73% 59 / 100   
1 Year -81.18% 9 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog